Next-Gen Cellular

Therapy for Cancer

The power of AI-driven cell training—innovating immunotherapy without genetic modification.

Advancing the future of cancer treatment worldwide.

Cellective AI is a cutting-edge biotech company pioneering a new approach to cancer therapy—training immune cells to fight tumors naturally, without genetic modifications

Advancing immunotherapy with next-gen cell training technology.

Advancing the next generation of cancer immunotherapy.

We conduct rigorous research to refine AI-driven cell training techniques, ensuring safety and effectiveness in real-world applications.

Expanding the Frontiers of Cancer Treatment

Our breakthrough cell training technology is designed to be adaptable, enabling the immune system to fight various forms of cancer and respond to emerging oncological challenges.

Partner collaboration and open innovation.

Our pioneering investors and partners are driving the future of AI-powered cancer treatment. Their vision fuels our mission to transform immunotherapy.

The Minds Behind the Innovation

Karl Heinrich Stoever

CEO

With over 35 years of expertise in leading technology innovation and manufacturing companies, he has driven disruptive strategies, spearheaded international expansion, and forged collaborations with major global corporations.

Huetzin Perez

CTO

A distinguished researcher with dual PhDs in Physics and Automation from the University of Guanajuato and Université Paris-Saclay, France. Holder of 50+ patents in communications and biomedical devices, he has been instrumental in advancing global technology. He has led at Lize Oledcomm México, OLEDCOM SAS (France), and Ellipz LiFi (Netherlands), driving industry innovations.

Jürgen Stoever

CMO

Strategic marketing and visual design expert with extensive experience in developing integrated digital campaigns and data-driven branding strategies. Specializes in optimizing brand-audience connections through innovative approaches and technical solutions, ensuring measurable results and sustainable market positioning.

Dr. Abraham Montes de Oca

Head of Medical Innovation

Facial and maxillofacial surgeon. Entrepreneur and innovator leading high-impact projects. Passionate about advancing longevity and improving quality of life.

Facundo Martín Diaz

Head of Deep Tech & Innovation

Deep Tech pioneer with expertise in quantum computing, artificial intelligence, blockchain, and virtual reality. Founder of /q99, TravelX, and VRTIFY—companies that have transformed industries like tourism and entertainment.

Gustavo Basurto Islas

CSO

Cell biology expert with a PhD and postdoctoral training at the Institute for Basic Research (NY). Renowned researcher in neurodegeneration, with numerous scientific publications and global recognitions. Dedicated to advancing biomedical validation and biotechnology.

A Breakthrough in Biotech Innovation

At Cellective AI, we are not just developing therapies—we are redefining how cancer is treated. By integrating biotechnology, AI, and immune system engineering, we are paving the way for a future where the body itself can fight cancer more effectively.